Virt-Phos 250 Neutral Interactions
There are 71 drugs known to interact with Virt-Phos 250 Neutral (potassium phosphate/sodium phosphate), along with 9 disease interactions. Of the total drug interactions, 28 are major, 28 are moderate, and 15 are minor.
- View all 71 medications that may interact with Virt-Phos 250 Neutral
- View Virt-Phos 250 Neutral disease interactions (9)
Most frequently checked interactions
View interaction reports for Virt-Phos 250 Neutral (potassium phosphate / sodium phosphate) and the medicines listed below.
- acyclovir
- albuterol
- amitriptyline
- amlodipine
- Aspir 81 (aspirin)
- aspirin
- Ativan (lorazepam)
- atorvastatin
- azithromycin
- carvedilol
- cinacalcet
- doxepin
- gabapentin
- hydralazine
- lisinopril
- losartan
- magnesium oxide
- melatonin
- metformin
- montelukast
- mycophenolate mofetil
- mycophenolic acid
- prednisone
- pregabalin
- spironolactone
- Symbicort (budesonide / formoterol)
- tacrolimus
- tramadol
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
Virt-Phos 250 Neutral disease interactions
There are 9 disease interactions with Virt-Phos 250 Neutral (potassium phosphate / sodium phosphate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
- aluminum toxicity/renal impairment
- cardiac disease
- hypomagnesemia
More about Virt-Phos 250 Neutral (potassium phosphate / sodium phosphate)
- Virt-Phos 250 Neutral consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: minerals and electrolytes
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.